InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: StockJumper25 post# 328229

Thursday, 10/15/2020 1:13:05 PM

Thursday, October 15, 2020 1:13:05 PM

Post# of 403020
the fda could give permission to start earlier than 30 days once they receive the ind

i noted that in the last PR ipix did not mention Q4 human trials even though they wanted to let us know the fda accepted the pre ind

realistically this is looking like a 2021 trial. With so many holidays during December, it might be a difficult time to start.

what kind of interim results are we looking at? what kind of dosing? how long is a dosing regimen? ipix knew all this info when they released their last Q report. That is how they were able to put a dollar amount on the cost to do a B for C trial. They knew how much b each patient would need and for how long. they hinted in a subsequent pr they will have excess b for other trials (most likely combo trial).

Just keep an eye out for the 5th Brilacidin trial
https://clinicaltrials.gov/ct2/results?cond=&term=brilacidin&cntry=&state=&city=&dist=



the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News